Neurological and mental disorders associated with COVID-19
https://doi.org/10.18705/1607-419X-2020-26-3-317-326
Abstract
The article presents a narrative review, clinical observations. Special attention is given to the pathogenesis, features of neurological manifestations and mental disorders, neurological complications in coronavirus infection, illustrated by clinical cases. Neurological disorders occur in approximately 36,4 % patients with COVID-19. Currently, severe viral hemorrhagic encephalitis, toxic encephalopathy, acute demyelinating lesions of the peripheral nervous system, stroke, behavioral and emotional disorders have been described. Despite numerous publications on the neurological pathology in COVID-19, pathogenesis, risk factors, and relation between neurological disorders and coronavirus infection remain unclear. There is a need for systematization of the accumulated data on the damage to the nervous system during the COVID-19 epidemic for clinical routine use, further development of the optimal treatment strategy and implementation of effective preventive measures.
About the Authors
L. B. Novikova
Bashkir State Medical University
Russian Federation
Russian Federation
Liliia B. Novikova, MD, PhD, DSc, Professor, Head, Department of Neurology, Institute for Continuing Professional Education (ICPE)
3 Lenin street, Ufa, 450008
Phone: 8(347)255–10–38
A. P. Akopian
Bashkir State Medical University
Russian Federation
Russian Federation
Anait P. Akopian, MD, PhD, Associate Professor, Department of Neurology, ICPE
Ufa
K. M. Sharapova
Bashkir State Medical University
Russian Federation
Russian Federation
Karina M. Sharapova, MD, Assistant, Department of Neurology, ICPE
Ufa
R. F. Latypova
Bashkir State Medical University
Russian Federation
Russian Federation
Raushaniya F. Latypova, MD, Assistant, Department of Neurology, ICPE
Ufa
References
1. Temporary guidelines. Prevention, diagnosis and treatment of new coronavirus infection (COVID-19). Version 6; April 28, 2020. Ministry of Health of the Russian Federation. In Russian.
2. Pérez CA. Looking ahead: The risk of neurologic complications due to COVID-19. Neurology: Clinical Practice. 2020. [Published online 9 April 2020]. doi:10.1212/CPJ.0000000000000836
3. Galougahi M, Ghorbani J, Bakhshayeshkaram M, Safavi Naeini A, Haseli S. Olfactory bulb magnetic resonance imaging in SARS-CoV-2-induced anosmia: the first report. Academic Radiology. 2020. [Ahead of print, published online 13 April 2020]. doi:10.1016/j.acra.2020.04.002
4. Wu Y, Xu X, Chen Z, Duan J, Hashimoto K, Yang L et al. Nervous system involvement after infection with COVID-19 and other coronaviruses. Brain Behav Immun. 2020. [Published online 28 March 2020]. doi:10.1016/j.bbi.2020.03.031
5. Nath A, Berger JR. Clinical neurovirology. Second edition. CRC Press; 2020. Р. 439–443.
6. Kuster G, Pfister O, Burkard T, Zhou Q, Twerenbold R, Haaf P et al. SARS-CoV2: should inhibitors of the renin–angiotensin system be withdrawn in patients with COVID-19? Eur Heart J. 2020. [Ahead of print, published online 20 March 2020]. doi:10.1093/eurheartj/ehaa235
7. Shi S, Qin M, Shen B, Cai Y, Liu T, Yang F et al. Association of cardiac injury with mortality in hospitalized patients with COVID-19 in Wuhan, China. JAMA Cardiol. 2020. [Ahead of print, published online 25 March 2020]. doi:10.1001/jamacardio.2020.0950
8. Machado C, Gutierrez J. Brainstem dysfunction SARS-CoV-2 infection can be a potential cause of respiratory distress. Preprints. 2020;2020040330. [Ahead of print, published online 19 April 2020]. doi:10.20944/preprints202004.0330.v1
9. Mao L, Jin H, Wang M, Hu Y, Chen S, He Q et al. Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan, China. JAMA Neurol.2020;77(6):683–690. doi:10.1001/jamaneurol.2020.1127
10. Asadi-Pooya A, Simani L. Central nervous system manifestations of COVID-19: a systematic review. J Neurol Sci. 2020; 413:116832. doi:10.1016/j.jns.2020.116832
11. Tang N, Li D, Wang X, Sun Z. Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia. J Thromb Haemost. 2020;18:844–847. doi:10.1111/jth.14768
12. COVID-19 and coagulopathy: frequently asked questions. Input from Drs. AYY Lee, JM Connors, L Baumann Kreuziger, M Murphy, T Gernsheimer, Y Lin. Version 2.0; last updated April 14, 2020. [Electronic resource]. URL: https://www.hematology.org/covid-19/covid-19-and-coagulopathy
13. COVID-19 and VTE/anticoagulation: frequently asked questions. Input from Drs. L Baumann Kreuziger, A Lee, D Garcia, A Cuker, M Cushman, JM Connors. Version 2.1; last updated April 17, 2020. [Electronic resource]. URL: https://www.hematology.org/covid-19/covid-19-and-vte-anticoagulation
14. Bikdeli B, Madhavan MV, Jimenez D, Chuich T, Dreyfus I, Driggin E. et al. COVID-19 and thrombotic or thromboembolic disease: implications for prevention, antithrombotic therapy, and follow-up. J Am Coll Cardiol. 2020. [Ahead of print, published online 15 April 2020]. doi:10.1016/j.jacc.2020.04.031
15. Temporary guidelines. Management of patients with acute cerebrovascular accident in the context of the COVID-19 pandemic. Version 1; April 6, 2020. In Russian.
16. Avula A, Nalleballe K, Narula N, Sapozhnikov S, Dandu V, Toom S, et al. COVID-19 presenting as stroke. Brain Behav Immunity. 2020. [Ahead of print, published online 27 April 2020]. doi:10.1016/j.bbi.2020.04.077
17. Oxley T, Mocco J, Majidi S, Kellner C, Shoirah H, Singh P et al. Large-vessel stroke as a presenting feature of Covid-19 in the young. N Engl J Med. 2020. [Ahead of print, published online 28 April 2020]. doi:10.1056/NEJMc2009787
18. Young K, Fairchild DG, Francesco LD. COVID-19: stroke in young adults/new presentation in kids/ACS admission. NEJM Journal Watch. Accessed May 6, 2020. [Electronic resource]. URL: https://www.jwatch.org/fw116590/2020/04/28/covid-19-strokeyoung-adults-new-presentation-kids-acs
19. Li Y, Wang M, Zhou Y, Chang J, Xian Y, Mao L. Acute cerebrovascular disease following COVID-19: a single center, retrospective, observational study. J Stroke. 2020. [Ahead of print, published online 17 April 2020]. doi:10.1016/j.jocn.2020.04.124
20. Needham E, Chou S, Coles A, Menon D. Neurological implications of COVID-19 infections. Neurocrit Care. 2020. [Ahead of print, published online 28 April 2020]. doi:10.1007/s12028-020-00978-4
21. Poyiadji N, Shahin G, Noujaim D, Stone M, Patel S, Griffith B. COVID 19-associated acute hemorrhagic necrotizing encephalopathy: CT and MRI features. Radiology. 2020. [Ahead of print, published online 3 March 2020]. doi:10.1148/radiol.2020201187
22. Moriguchia T, Hariib N, Gotoa J, Haradaa D, Sugawaraa H, Takaminoa J et al. A first of meningitis/encephalitis associated with SARS-Coronavirus-2. Intern J Infect Dis. 2020;94:55–58. doi:10.1016/j.ijid.2020.03.062
23. Fung Wong P, Craik S, Newman P, Makan A, Srinivasan K, Crawford E et al. Lessons of the month 1: A case of rhombencephalitis as a rare complication of acute COVID-19 infection. Clin Med. 2020;20(3):1–2. doi:10.7861/clinmed.2020-0182
24. Filatov A, Sharma P, Hindi F, Espinosa P. Neurological complications of coronavirus disease (COVID-19): encephalopathy. Cureus. 2020;12(3): e7352. doi:10.7759/cureus.7352
25. Helms J, Kremer S, Merdji H, Clere-Jehl R, Schenck M, Kummerlen C et al. Neurologic features in severe SARS-CoV-2 infection. N Engl J Med. 2020. [Ahead of print, published online 7 May 2020]. doi:10.1056/NEJMc2008597
26. Zhao H, Shen D, Zhou H, Liu J, Chenet S. Guillen-Barre syndrome associated with SARS-CoV-2 infection: causality or coincidence? Lancet. 2020;19(5):383–384. doi:10.1016/S1474-4422(20)30109-5
27. Toscano G, Palmerini F, Ravaglia S, Ruiz L, Invernizzi P, Cuzzoni G et al. Guillain–Barré syndrome associated with SARSCoV-2. N Engl J Med. 2020. [Ahead of print, published online 2 May 2020]. doi:10.1056/NEJMc2009191
28. Gutierrez C, Mendez A, Rodrigo-Rey S, San PedroMurillo E, Bermejo-Guerrero L, Gordo-Mañas R et al. Miller Fisher syndrome and polyneuritis cranialis in COVID-19. Neurology. 2020. [Ahead of print, published online 17 April 2020]. doi:10.1212/WNL.0000000000009619
29. Dinkin M, Gao V, Kahan J, Bobker S, Simonetto M, Wechsler P et al. COVID-19 presenting with ophthalmoparesis from cranial nerve palsy. Neurology. 2020. [Ahead of print, published online 1 May 2020]. doi:10.1212/WNL.0000000000009700
30. Dong L, Bouey J. Public mental health crisis during COVID-19 Pandemic, China. Emerging infectious diseases. 2020;26(7). [Ahead of print, published online 23 March 2020]. doi:10.3201/eid2607.200407
31. Li W, Yang Y, Liu Z, Zhao Y, Zhang Q, Zhang L et al. Progression of Mental Health Services during the COVID-19 Outbreak in China. Int J Biol Sci. 2020;16(10):1732–1738. doi:10.7150/ijbs.45120
32. Schwati BJ. New Poll: COVID-19 Impacting mental well-being: American feeling anxious, especially for loved ones. APA News releases. [Published online 25 March 2020]. [Electronic resource]. URL: https://www.psychiatry.org/newsroom/news-releases/new-poll-covid-19-impacting-mental-well-being-americans-feeling-anxious-especially-for-loved-ones-older-adults-are-less-anxious
33. Rossi R, Socci V, Talevvi D, Mensi S, Niolu C, Pacitti F et al. COVID-19 pandemic and lockdown measure impact on mental health among the general population in Italy. МedRxiv preprint. [Ahead of print, published online 14 April 2020]. doi:10.1101/2020.04.09.20057802
34. Brooks SK, Webster RK, Smith LE, Woodland L, Wessely S, Greenberg N et al. The psychological impact of quarantine and how to reduce it: rapid review of the evidence. Lancet. 2020;395(10227):912–920. doi:10.1016/S0140-6736(20)30460-8
35. Gales S, Merchant RM, Lurie N. The mental health consequences of COVID-19 and physical distancing: the need for prevention and early intervention. JAMA Intern Med. 2020. [Ahead of print, published online 10 April 2020]. doi:10.1001/jamainternmed.2020.1562
36. Tubbs AS, Perlis ML, Basner M, Chakravorty S, Khader W, Fernandez F et al. Relationship of nocturnal wakefulness to suicide risk across months and methods of suicide. J Clin Psychiatry. 2020;81(2):19m12964. doi:10.4088/JCP.19m12964
37. Kang L, Li Y, Hu S, Chen M, Yang BX. The mental health of medical workers in Wuhan, China dealing with the 2019 novel coronavirus. Lancet Psychiatry. 2020;7(3):e14. doi:10.1016/S2215-0366(20)30047-X
38. Coronavirus disease 2019 (COVID-19) Situation report-45. World Health Organisation. March 5, 2020. [Electronic resource]. URL: https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200305-sitrep-45-covid-19.pdf?sfvrsn=ed2ba78b_2
Review
For citations:
Novikova L.B., Akopian A.P., Sharapova K.M., Latypova R.F. Neurological and mental disorders associated with COVID-19. "Arterial’naya Gipertenziya" ("Arterial Hypertension"). 2020;26(3):317-326. (In Russ.) https://doi.org/10.18705/1607-419X-2020-26-3-317-326
Views:
2548
Email this article 